DryShips, Dillard's, Sangamo Stocks Moving Today

Three stocks making big moves on the charts today are DryShips, Dillard's, Sangamo Therapeutics

May 11, 2017 at 1:51 PM
facebook twitter linkedin


The Dow is off its lows, but the broader stock market remains negative territory. Among specific stocks on the move are bulk shipper DryShips Inc. (NASDAQ:DRYS), retailer Dillard's, Inc. (NYSE:DDS), and biotech Sangamo Therapeutics Inc (NASDAQ:SGMO). Here's a quick look at what's moving shares of DRYS, DDS, and SGMO.

DRYS Stock Plummets Again After Quarterly Results

DRYS stock is down 18.4% today at $5.48 -- putting it on the short-sale restricted (SSR) list and near the bottom of the Nasdaq -- following disappointing quarterly results. It's been a wild year for DryShips stock, which underwent a 1-for-7 reverse split that took effect today, and short sellers apparently see more losses ahead. Specifically, short interest increased by 86% over the past two reporting periods. 

DDS Stock Joins Retail Sell-Off

DDS is just another retail stock getting crushed today after earnings, last seen 17.5% lower at $47.75, and on the SSR list. J.P. Morgan Securities lowered its price target to $41 from $44 on the stock, which sits in territory not seen since late 2011. Dillard's shares are now down almost 24% year-over-year, and DDS options traders have been betting on more downside, albeit amid relatively low absolute volume. DDS has a 10-day put/call volume ratio of 3.53 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which is higher than 72% of readings from the past year. 

SGMO Tops the Nasdaq After Pfizer Deal

Following better-than-expected quarterly results and a new collaboration with Pfizer Inc. (NYSE:PFE), SGMO is soaring, up 51.1% at $6.58, making it the top percentage gainer on the Nasdaq. The stock has now more than doubled year-to-date, taking out recent resistance at its 320-day moving average. Analysts were already bullish on Sangamo Therapeutics stock, with two-thirds of covering brokerage firms issuing "strong buy" recommendations. 


A Schaeffer's exclusive!

The Expert's Guide

Access your FREE trading earnings guide for Q3 before it's too late!


  
 
Special Offers from Schaeffer's Trading Partners